Quanterix Corp (QTRX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $139.11M
Last updated: Nov 17, 2026 at 11:06 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 6.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 45.6, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about QTRX
Government Contracts
Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies
Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.
News
QTRX Valuation
QTRX Profitability: Margins, ROIC and FCF
Quanterix (QTRX) has a gross margin of 41.7%, an operating margin of -53.6% and a net margin of -75.0%. It posts a -38.0% FCF margin.
- Gross margin
- 41.7%
- Operating margin
- -53.6%
- Net margin
- -75.0%
- ROE
- -41.6%
- FCF margin
- -38.0%
- FCF yield
- -41.8%
Quanterix Competitors
The companies most similar to Quanterix (QTRX) include QuantumSi, MaxCyte and TriSalus Life Sciences.
Sector: Healthcare
Companies most similar to QuanterixQTRX Analyst Ratings
Quanterix (QTRX) has a Hold consensus from 3 analysts: 0 Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell.
- Consensus
- Hold
- Analysts
- 3
- Strong Buy
- 0
- Buy
- 0
- Hold
- 3
- Sell
- 0
- Strong Sell
- 0
QTRX Bull Case vs Bear Case
Bear case
- QTRX has a -75.0% net profit margin.
- QTRX beat EPS estimates in 37.5% of its last 8 reported quarters.
- QTRX's quarterly revenue changed -13.1% year over year.
QTRX Earnings: Beat Rate and Next Report
Quanterix (QTRX) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Jan 6, 2027.
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- 6.1%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.41
QTRX Earnings Date
QTRX reports Jan 6, 2027. The date is estimated.
QTRX Earnings Call
The latest QTRX earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptQTRX ETF Holders
GNG tracks 7 ETFs that hold QTRX. The largest weights:
- Fidelity Enhanced Small Cap Core ETF (FESM), 0.01% of the fund
- iShares Biotechnology ETF (IBB), 0.01% of the fund
- iShares Russell 2000 ETF (IWM), 0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About QTRX
When does QTRX report earnings?
Quanterix Corp (QTRX) is expected to report earnings on Jan 6, 2027.
Does QTRX pay dividends?
Quanterix Corp (QTRX) does not currently pay a regular dividend.
What is QTRX's market cap?
Quanterix Corp (QTRX) has a market capitalization of $139.11M with a current stock price of $2.84.
QTRX pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.